Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...

The average homeowner selling up last year across England and Wales sold their property for £91,260 more than they paid, ...

The Wegovy pill comes in tablet form—and is the first U.S. Food & Drug Administration (FDA)-approved GLP-1 to do so. Its ...

The UK’s medicines regulator has approved a stronger dose of the weight loss jab Wegovy as demand for the drug is set to soar ...

For months prior to the 2025 NBA Draft, it was clear that, regardless of which team won the Draft Lottery, Cooper Flagg was ...

GLP-1 weight-loss pills appear to be just as effective as injections, with clinical trials showing similar average weight ...

People taking weight-loss drugs are likely to regain the weight they have lost within two years of stopping the medications, ...

Imagine the financial damage if a 2008-style market crash happened today. Read about how much the average investor could lose if markets plunge again.

"That’s surprisingly quick – almost four times faster than the weight regain seen after stopping weight-loss programmes based ...

They’ve been hailed as game-changers for weight loss, but new research suggests the results may not last. From how the ...

People who stop taking weight-loss jabs such as Wegovy regain pounds much faster than those who halt exercising and dieting, ...

More than 1.5 million people are using weight loss medication in the UK but new data has shown what happens when the ...